Novel and Latest Computational Routes in the Design and Development of Anticancer Drugs-Reference-Cited by-同舟云学术

Novel and Latest Computational Routes in the Design and Development of Anticancer Drugs

Published:2024-02 Issue:5 Volume:31 Page:552-553
ISSN:0929-8673
Container-title:Current Medicinal Chemistry
language:en
Short-container-title:CMC

Author:

Kamal Mohammad Amjad¹,Akhtar Salman²

Affiliation:

1. Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China

2. Department of Bioengineering, Faculty of Engineering & Information Technology, Integral University, Dasauli, Kursi Road Lucknow – 226026 India

Abstract

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry

Reference6 articles.

1. Talluri S.; Kamal M.A.; Malla R.R.; Novel computational methods for cancer drug design. Curr Med Chem 2024,31(5),554-572

2. Ghosh A.; Ghosh D.; Mukerjee N.; et al. The efficient activity of glabridin and its derivatives against EGFR-mediated inhibition of breast cancer. Curr Med Chem 2024,31(5),573-594

3. Shah A.A.; Ahmad S.; Yadav M.K.; Raza K.; Kamal M.A.; Akhtar S.; Structure-based virtual screening, molecular docking, molecular dynamics simulation, and metabolic reactivity studies of quinazoline derivatives for their anti-EGFR activity against tumor angiogenesis. Curr Med Chem 2024,31(5),595-619

4. Alam S.; Verma S.; Fatima K.; Luqman S.; Srivastava S.K.; Khan F.; Pharmacophore and QSAR guided design, synthesis, pharmacokinetics, and in vitro evaluation of curcumin analogs for anticancer activity. Curr Med Chem 2024,31(5),620-639

5. Ahmad S.; lshammari, Q.T.; Rafi, Z. et al. Generation of autoantibodies in metal-catalyzed oxidatively damaged DNA in various cancer subjects. Curr Med Chem 2024,31(5),640-648